查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405866

糖尿病视网膜病变市场规模、份额、趋势分析报告：按类型、管理、地区、细分市场预测，2024-2030 年

Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative DR, Non-Proliferative DR), By Management (Anti-VEGF Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Region, & Segment Forecasts, 2024-2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

糖尿病视网膜病变市场成长与趋势：

Grand View Research, Inc.最新报告预测，到2030年，全球糖尿病视网膜病变市场规模预计将达到137.7亿美元，2024年至2030年复合年增长率为6.43%。

糖尿病盛行率上升、老年人口增加以及糖尿病导致失明率上升是预计在预测期内推动市场成长的主要因素。有关糖尿病管理和护理的意识不断提高和新产品的推出进一步推动了市场成长。糖尿病视网膜病变是由视网膜血管损伤引起的，通常会导致Sumiya Co., Ltd.和视力下降。

由于高龄化、肥胖和不健康的生活方式，糖尿病盛行率不断上升，推动了市场的成长。肥胖是引发糖尿病的主要因素。据世界卫生组织称，到 2021 年，全球 18 岁以上成年人中约有 39% 超重，13% 肥胖。除了肥胖之外，糖尿病在世界各地也变得越来越普遍。根据国际糖尿病联盟（IDF）估计，2021年将有5.37亿成年人（20岁至79岁）患有糖尿病，预计2040年将增加至6.42亿。 IDF 还报告称，全球糖尿病盛行率正在上升，其中低收入和中等收入国家的增幅最高。 2021年糖尿病患者人数最多的地区是亚太地区（1.67亿人）、南亚（8,800万人）和欧洲（5,900万人）。

老年人口的增加是糖尿病流行的重要驱动因素，因为老年人的糖尿病与死亡率增加和功能状态下降有直接关係。据世界卫生组织称，到2050年，预计80%的老年人将生活在低收入和中等收入国家。人口高龄化速度比过去高很多。 2020年，60岁以上老年人口数量超过5岁以下儿童数。 2015年至2050年间，全球60岁以上人口比例将增加近一倍，从12%增加至22%。

糖尿病视网膜病变市场报告亮点

  • 就2023年按类型分類的份额而言，非增殖性糖尿病视网膜病变将占最大份额。大量糖尿病史不到10年的患者增加了该细分市场的市场规模。
  • 2023年，依管理层划分，抗VEGF药物领域占最大份额。这些药物在治疗轻中度非增殖性 DR 的早期诊断和高适用性是指导此细分市场成长的主要因素之一。
  • 预计亚太市场在预测期内将以最高复合年增长率成长。该地区人口众多、糖尿病盛行率高以及老年人口不断增加可能会增强该市场。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章 糖尿病视网膜病变市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 糖尿病视网膜病变市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章 糖尿病视网膜病变市场：类型估计与趋势分析

  • 类型市场占有率，2023/2030
  • 细分仪表板
  • 按类型分類的全球糖尿病视网膜病变市场展望
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 增殖性糖尿病视网膜病变
    • 非增殖性糖尿病视网膜病变

第五章糖尿病视网膜病变市场：管理阶层估计与趋势分析

  • 管理市场占有率，2023/2030
  • 细分仪表板
  • 按管理前景分類的全球糖尿病视网膜病变市场
  • 2018-2030 年市场规模、预测与趋势分析如下
    • 抗VEGF
    • 类固醇眼内注射
    • 雷射手术
    • 玻璃体切除术

第六章 糖尿病视网膜病变市场：区域估计与趋势分析

  • 2023/2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030 年市场规模与预测/趋势分析：
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Bayer AG
    • ABBVIE INC.
    • Novartis AG
    • Oxurion NV
    • Sirnaomics
    • Alimera Sciences
    • Ampio Pharmaceuticals Inc.
    • BCNPeptides
    • Kowa Company Ltd.
    • Genentech, Inc.
Product Code: 978-1-68038-466-6

Diabetic Retinopathy Market Growth & Trends:

The global diabetic retinopathy market size is anticipated to reach USD 13.77 billion by 2030 and is anticipated to expand at a CAGR of 6.43% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of diabetes, growing geriatric population, and increasing prevalence of blindness due to diabetes are the major factors anticipated to boost market growth over the forecast period. Growth in the market is further propelled by the increasing awareness about diabetes management & care and new product launches. Diabetic retinopathy is caused by damage to the blood vessels in the retina, which leads to blurred vision and vision loss in most cases.

The increase in prevalence of diabetes due to aging, obesity, and unhealthy lifestyles is contributing to the growth of the market. Obesity is a major factor leading to diabetes. According to WHO, in 2021, around 39% of adults aged 18 years and above were overweight, and 13% were obese worldwide. In addition to obesity, diabetes is becoming increasingly prevalent globally. The International Diabetes Federation (IDF) estimated l537 million adults (aged 20 to 79 years) were living with diabetes in 2021, which is expected to rise to 642 million by 2040. The IDF also reports that the prevalence of diabetes is increasing globally, with the highest increases witnessed in low- and middle-income countries. In 2021, the regions with the highest number of adults living with diabetes were the Western Pacific (167 million), South Asia (88 million), and Europe (59 million).

The rising geriatric population is a significant driver of the diabetes epidemic, as diabetes in older people is directly linked with higher mortality and reduced functional status. According to WHO, 80% of older people are expected to live in low- and middle-income nations by 2050. The population is aging at a considerably higher rate than in the past. In 2020, the number of persons aged 60 years and more will outnumber children under the age of 5 years. Between 2015 and 2050, the proportion of the global population aged over 60 years will nearly double, from 12% to 22%.

Diabetic Retinopathy Market Report Highlights:

  • Non-proliferative diabetic retinopathy accounted for the largest share, by type, in 2023. The presence of large number of patients within the bracket of less than 10 years of diabetic history contributed to the large size of this segment.
  • Anti-VEGF segment accounted for the largest share, by management, in 2023. High applicability of these drugs in treatment of early diagnosis and mild to moderate cases of non-proliferative DR treatment is among the prime factors leading to segmental growth.
  • The Asia Pacific market is expected to grow with the highest CAGR over the forecast period. Large population base in this region, high prevalence of diabetes, and rising geriatric population are likely to bolster the market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Management
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Management outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Diabetic Retinopathy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of diabetes
      • 3.2.1.2. Growing geriatric population
      • 3.2.1.3. Increasing prevalence of blindness due to diabetes
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Lack of accurate diagnosis
      • 3.2.2.2. Adverse effect on treatment
  • 3.3. Diabetic Retinopathy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Diabetic Retinopathy Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Diabetic Retinopathy Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Proliferative Diabetic Retinopathy
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Non-proliferative Diabetic Retinopathy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Diabetic Retinopathy Market: Management Estimates & Trend Analysis

  • 5.1. Management Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Diabetic Retinopathy Market by Management Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Anti-VEGF
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Intraocular Steroid Injection
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Laser Surgery
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Vitrectomy
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Diabetic Retinopathy Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Bayer AG
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. ABBVIE INC.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Novartis AG
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Oxurion NV
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Sirnaomics
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Alimera Sciences
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Ampio Pharmaceuticals Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. BCNPeptides
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Kowa Company Ltd.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Genentech, Inc.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 5 U.S. refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 6 U.S. refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 7 Canada refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 8 Canada refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 9 Europe refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Europe refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 12 Germany refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 13 Germany refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 14 UK refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 15 UK refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 16 France refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 17 France refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 18 Italy refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Italy refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 20 Spain refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 21 Spain refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 22 Denmark refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 23 Denmark refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 24 Sweden refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Sweden refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 26 Norway refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Norway refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 31 China refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 32 China refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 33 Japan refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 34 Japan refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 35 India refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 36 India refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 37 South Korea refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 38 South Korea refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 39 Australia refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Australia refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 41 Thailand refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Thailand refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 43 Latin America refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 44 Latin America refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 45 Brazil refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 46 Brazil refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 47 Mexico refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Mexico refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 49 Argentina refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Argentina refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 51 MEA refurbished MRI systems market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 53 MEA refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 54 South Africa refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Africa refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 58 UAE refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 59 UAE refurbished MRI systems market, by management, 2018 - 2030 (USD Million)
  • Table 60 Kuwait refurbished MRI systems market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Kuwait refurbished MRI systems market, by management, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Refurbished MRI systems market: market outlook
  • Fig. 14 Refurbished MRI systems competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Refurbished MRI systems market driver impact
  • Fig. 20 Refurbished MRI systems market restraint impact
  • Fig. 21 Refurbished MRI systems market strategic initiatives analysis
  • Fig. 22 Refurbished MRI systems market: Type movement analysis
  • Fig. 23 Refurbished MRI systems market: Type outlook and key takeaways
  • Fig. 24 Proliferative diabetic retinopathy market estimates and forecast, 2018 - 2030
  • Fig. 25 Non-proliferative diabetic retinopathy estimates and forecast, 2018 - 2030
  • Fig. 26 Refurbished MRI systems Market: Management movement Analysis
  • Fig. 27 Refurbished MRI systems market: Management outlook and key takeaways
  • Fig. 28 Anti-VEGF market estimates and forecasts, 2018 - 2030
  • Fig. 29 Laser surgery market estimates and forecasts,2018 - 2030
  • Fig. 30 Vitrectomy market estimates and forecasts,2018 - 2030
  • Fig. 31 Global refurbished MRI systems market: Regional movement analysis
  • Fig. 32 Global refurbished MRI systems market: Regional outlook and key takeaways
  • Fig. 33 Global refurbished MRI systems market share and leading players
  • Fig. 34 North America market share and leading players
  • Fig. 35 Europe market share and leading players
  • Fig. 36 Asia Pacific market share and leading players
  • Fig. 37 Latin America market share and leading players
  • Fig. 38 Middle East & Africa market share and leading players
  • Fig. 39 North America: SWOT
  • Fig. 40 Europe SWOT
  • Fig. 41 Asia Pacific SWOT
  • Fig. 42 Latin America SWOT
  • Fig. 43 MEA SWOT
  • Fig. 44 North America, by country
  • Fig. 45 North America
  • Fig. 46 North America market estimates and forecasts, 2018 - 2030
  • Fig. 47 U.S.
  • Fig. 48 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 49 Canada
  • Fig. 50 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 51 Europe
  • Fig. 52 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 53 UK
  • Fig. 54 UK market estimates and forecasts, 2018 - 2030
  • Fig. 55 Germany
  • Fig. 56 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 57 France
  • Fig. 58 France market estimates and forecasts, 2018 - 2030
  • Fig. 59 Italy
  • Fig. 60 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 61 Spain
  • Fig. 62 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 63 Denmark
  • Fig. 64 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 65 Sweden
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 67 Norway
  • Fig. 68 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 71 China
  • Fig. 72 China market estimates and forecasts, 2018 - 2030
  • Fig. 73 Japan
  • Fig. 74 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 75 India
  • Fig. 76 India market estimates and forecasts, 2018 - 2030
  • Fig. 77 Thailand
  • Fig. 78 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 79 South Korea
  • Fig. 80 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 81 Australia
  • Fig. 82 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 83 Latin America
  • Fig. 84 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 85 Brazil
  • Fig. 86 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 87 Mexico
  • Fig. 88 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 89 Argentina
  • Fig. 90 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 91 Middle East and Africa
  • Fig. 92 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 93 South Africa
  • Fig. 94 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 95 Saudi Arabia
  • Fig. 96 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 97 UAE
  • Fig. 98 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 99 Kuwait
  • Fig. 100 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 101 Market share of key market players - Diabetic retinopathy market